Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 09 Jul 2012 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. S&P 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | ICICI Prudential US Bluechip Equity Fund |
|---|---|
| 09 Jul 2012 | ₹100.00 |
| 12 Sep 2013 | ₹150.34 |
| 15 Nov 2014 | ₹171.72 |
| 19 Jan 2016 | ₹167.49 |
| 23 Mar 2017 | ₹200.89 |
| 27 May 2018 | ₹240.00 |
| 31 Jul 2019 | ₹275.27 |
| 02 Oct 2020 | ₹330.54 |
| 06 Dec 2021 | ₹451.33 |
| 08 Feb 2023 | ₹488.08 |
| 13 Apr 2024 | ₹562.27 |
| 16 Jun 2025 | ₹612.91 |
| 20 Aug 2026 | ₹810.34 |
| Metric | ICICI Prudential · Regular NAV ₹82.25 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +23.95% | +5.83% | |
| +16.87% | +15.63% | |
| +12.58% | +13.23% | |
| +15.37% | +13.85% | |
| +15.98% | +12.26% | |
| +16.98% | — | |
| +14.29% | +15.60% | |
| +14.52% | +14.52% | |
| +14.24% | +13.74% | |
| Risk | ||
| 16.25% | 15.62% | |
| 0.64 | 0.43 | |
| 0.96 | 0.59 | |
| -24.69% | -23.65% | |
| S&P 500 | — | |
| -0.79% | +3.42% | |
| 0.83 | 0.95 | |
| 91.7% | 105.9% | |
| 107.1% | 93.6% | |
| 1.96% | 2.39% | |
| ₹3,584Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 52% | 45% | |
| Sharmila D'silva | — | |
| 09 Jul 2012 | — | |
| — | — | |
| — | — | |
| 3.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.